Insulin Adjustment Recommendations
This patient requires immediate and aggressive insulin dose adjustments: increase the Lantus basal dose to approximately 22 units daily (0.2 units/kg), tighten the ICR to 1:10, and strengthen the ISF to 1:40, with close monitoring over the next 3-5 days given the significant hyperglycemia and olanzapine-induced insulin resistance.
Critical Context: Olanzapine's Impact
This patient is on olanzapine 5 mg BID (10 mg total daily), which is a major contributor to her poor glycemic control. Olanzapine is among the most diabetogenic atypical antipsychotics, causing severe insulin resistance and hyperglycemia through multiple mechanisms 1, 2. The drug interactions are explicit: atypical antipsychotics like olanzapine decrease the blood glucose-lowering effect of insulin, requiring dosage increases and more frequent monitoring 1.
Analysis of Current Insulin Regimen Failure
Your patient's glucose data reveals profound insulin inadequacy:
- Morning BG 364 mg/dL after eating 69g carbs
- Afternoon BG 409 mg/dL (6 hours later, suggesting both bolus and basal failure)
- Current ICR of 1:12 would have given ~5.75 units for 69g carbs
- Current ISF of 1:50 would add ~4.3 units correction (from 364)
- Total bolus ~10 units failed to prevent BG rising to 409
This represents both:
- Inadequate basal insulin (allowing baseline drift upward)
- Insufficient bolus coverage (ICR and ISF both too weak)
Basal Insulin (Lantus) Adjustment
Starting Dose Calculation
For type 2 diabetes patients not previously on insulin, guidelines recommend 10 units or 0.2 units/kg daily 3, 4. At 110 kg:
- 0.2 units/kg = 22 units daily
Initiate Lantus at 22 units once daily (same time each day). This is appropriate given her weight and the severity of hyperglycemia (both readings >300 mg/dL) 3, 4.
Titration Protocol
Use an evidence-based algorithm, increasing 2 units every 3 days until fasting plasma glucose reaches 80-130 mg/dL 3. More aggressive titration (4 units every 3 days) is justified when FPG remains >180 mg/dL 5, 6.
Target fasting glucose: 100-130 mg/dL initially (can tighten to 80-110 mg/dL once stable).
Monitoring for Overbasalization
Watch for clinical signals suggesting basal doses are excessive (typically >0.5-1.0 units/kg or ~55-110 units in this patient) without achieving targets 7, 5. If basal exceeds these thresholds without glycemic improvement, consider adding GLP-1 RA rather than further basal escalation 3.
Insulin-to-Carbohydrate Ratio (ICR) Adjustment
Current ICR of 1:12 is clearly inadequate. The patient consumed 69g carbs, received ~5.75 units, yet glucose rose from 364 to 409 mg/dL.
Tighten ICR to 1:10 (1 unit per 10g carbs):
- This represents a 20% increase in bolus insulin
- For 69g carbs: would give 6.9 units (vs. current 5.75 units)
- Type 2 diabetes patients are typically more insulin resistant, often requiring ratios of 1:8 to 1:12 7
Further Titration
If postprandial glucose remains >180 mg/dL 2 hours after meals with 1:10 ratio, tighten further to 1:8 after 3-5 days of observation.
Insulin Sensitivity Factor (ISF) Adjustment
Current ISF of 1:50 is too weak. The correction dose of ~4.3 units (for BG 364) failed to prevent further rise to 409 mg/dL.
Strengthen ISF to 1:40 (1 unit lowers glucose by 40 mg/dL):
- This represents a 25% increase in correction doses
- For BG 364 with target 120: (364-120)/40 = 6.1 units correction
- Combined with meal bolus: more aggressive glucose reduction
Rule of Thumb
A common starting ISF calculation is 1800 ÷ total daily insulin dose. Once basal is optimized (estimated 40-50 units total daily insulin with basal + bolus), ISF would be approximately 1800/45 = 1:40, confirming this recommendation 5.
Critical Medication Interaction Management
Furosemide 40 mg daily can also impair glucose tolerance, though less significantly than olanzapine 1. Monitor for:
- Volume depletion (can concentrate glucose)
- Electrolyte abnormalities affecting insulin secretion
Immediate Action Plan
- Tonight: Start Lantus 22 units at bedtime (or same time daily)
- Tomorrow: Implement ICR 1:10 and ISF 1:40 for all meals
- Days 1-3: Monitor fasting and pre-meal glucose 4 times daily
- Day 4: Increase Lantus by 2-4 units if fasting glucose >130 mg/dL
- Days 4-7: Continue monitoring, adjust ICR/ISF if postprandial targets not met
- Week 2: Reassess total regimen, expect basal needs of 30-40 units
Hypoglycemia Precautions
With more aggressive dosing, prescribe glucagon for emergency hypoglycemia 3. Educate on recognition and treatment of hypoglycemia. If BG <70 mg/dL occurs, reduce the corresponding insulin dose by 10-20% 3, 4.
Long-term Considerations
- Consider GLP-1 RA addition (e.g., semaglutide) to reduce insulin requirements and promote weight loss, particularly important given olanzapine-induced weight gain 3, 7
- Discuss olanzapine alternatives with prescribing psychiatrist if glycemic control remains poor despite optimized insulin
- Target total daily insulin: 0.5-1.0 units/kg (55-110 units) may be needed given severe insulin resistance 7, 5